EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
01 1EUROAPI FRANCE Vertolaye FR
02 1CORAL DRUGS PRIVATE LIMITED New Delhi IN
03 1Coral Drugs Private Limited New Delhi IN
04 1Vamsi Labs Limited Solapur IN
05 1Farmabios SpA Gropello Cairoli IT
06 1SANOFI CHIMIE Gentilly FR
07 1WAVELENGTH ENTERPRISES LTD. Petah Tikva IL
08 1AARTI PHARMALABS LIMITED Mulund (W), Mumbai IN
09 2AURISCO PHARMACEUTICAL CO., LTD. Tiantai CN
10 2BREATHGREEN PHARMACEUTICAL CO. LTD. Zaozhuang City CN
11 4CIPLA LIMITED Mumbai IN
12 1CURIA SPAIN S.A.U. Boecillo ES
13 1FERMION OY Espoo FI
14 1GlaxoSmithKline Research & Development Limited London GB
15 1HOVIONE FARMACIENCIA S.A. Loures PT
16 1Hovione FarmaCiencia S.A. Loures PT
17 1Industriale Chimica S.R.L. Saronno IT
18 1MYLAN LABORATORIES LIMITED Hyderabad IN
19 1NEWCHEM S.p.A. Milano IT
20 1SHANDONG SIRUI PHARMACEUTICAL CO., LTD. Heze CN
21 4STERLING S.p.A. Solomeo Di Corciano IT
22 1SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai IN
23 1TEVA PHARMACEUTICAL INDUSTRIES LTD Tel Aviv - Jaffa IL
01 15Fluticasone propionate
02 1Fluticasone propionate, Anti-solvent Crystallized Code 2000111
03 1Fluticasone propionate, Anti-solvent Crystallized Code 2000134
04 1Fluticasone propionate, Code 2000116
05 4Fluticasone propionate, Micronised
06 2Fluticasone propionate, Micronised, non-micronised
07 1Fluticasone propionate, Modified Process II, Micronised
08 1Fluticasone propionate, Non-micronised, micronised
09 1Fluticasone propionate, Process 1
10 1Fluticasone propionate, Process FCPB
11 1Fluticasone propionate, Process I
12 1Fluticasone propionate, Process II, micronised, grades I and II
13 1Fluticasone propionate, Process III, micronised grade I, II, III
01 3China
02 1Finland
03 3France
04 9India
05 1Israel
06 7Italy
07 2Portugal
08 1Spain
09 3U.S.A
10 1United Kingdom
01 3Expired
02 26Valid
03 2Withdrawn by Holder
Fluticasone Propionate, Non-micronised, Micronis...
Certificate Number : R1-CEP 2018-040 - Rev 00
Status : Valid
Issue Date : 2023-05-03
Type : Chemical
Substance Number : 1750
Certificate Number : R1-CEP 2005-055 - Rev 03
Status : Valid
Issue Date : 2020-09-25
Type : Chemical
Substance Number : 1750
Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.
Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.
Fluticasone Propionate, Micronised
Certificate Number : CEP 2020-078 - Rev 02
Status : Valid
Issue Date : 2023-12-11
Type : Chemical
Substance Number : 1750
Fluticasone Propionate, Micronised
Certificate Number : CEP 2008-117 - Rev 02
Status : Valid
Issue Date : 2024-05-23
Type : Chemical
Substance Number : 1750
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Certificate Number : R0-CEP 2013-158 - Rev 02
Status : Expired
Issue Date : 2016-07-08
Type : Chemical
Substance Number : 1750
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
Certificate Number : CEP 2007-192 - Rev 09
Status : Valid
Issue Date : 2024-11-26
Type : Chemical
Substance Number : 1750
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
Certificate Number : R1-CEP 2007-262 - Rev 03
Status : Valid
Issue Date : 2022-10-14
Type : Chemical
Substance Number : 1750
Fluticasone Propionate, Process 1
Certificate Number : R0-CEP 2021-492 - Rev 00
Status : Valid
Issue Date : 2023-06-01
Type : Chemical
Substance Number : 1750
Certificate Number : CEP 2023-306 - Rev 00
Status : Valid
Issue Date : 2024-07-19
Type : Chemical
Substance Number : 1750
Certificate Number : R1-CEP 2005-160 - Rev 02
Status : Valid
Issue Date : 2019-02-27
Type : Chemical
Substance Number : 1750
A Flixotide Inhaler manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Flixotide Inhaler, including repackagers and relabelers. The FDA regulates Flixotide Inhaler manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Flixotide Inhaler API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Flixotide Inhaler manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Flixotide Inhaler supplier is an individual or a company that provides Flixotide Inhaler active pharmaceutical ingredient (API) or Flixotide Inhaler finished formulations upon request. The Flixotide Inhaler suppliers may include Flixotide Inhaler API manufacturers, exporters, distributors and traders.
click here to find a list of Flixotide Inhaler suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Flixotide Inhaler CEP of the European Pharmacopoeia monograph is often referred to as a Flixotide Inhaler Certificate of Suitability (COS). The purpose of a Flixotide Inhaler CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Flixotide Inhaler EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Flixotide Inhaler to their clients by showing that a Flixotide Inhaler CEP has been issued for it. The manufacturer submits a Flixotide Inhaler CEP (COS) as part of the market authorization procedure, and it takes on the role of a Flixotide Inhaler CEP holder for the record. Additionally, the data presented in the Flixotide Inhaler CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Flixotide Inhaler DMF.
A Flixotide Inhaler CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Flixotide Inhaler CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Flixotide Inhaler suppliers with CEP (COS) on PharmaCompass.
We have 20 companies offering Flixotide Inhaler
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?